Patents by Inventor Lone Jeppesen

Lone Jeppesen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted hetero-polycyclic compounds as PPARalpha and PPARgamma activators
    Publication number: 20020103188
    Abstract: The present invention relates-to compounds of the general formula (I) 1
    Type: Application
    Filed: February 8, 2002
    Publication date: August 1, 2002
    Inventors: Lone Jeppesen, Paul Stanley Bury, Per Sauerberg
  • Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
    Patent number: 6407127
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, Ar, X, Q, A, Y and Z are as defined in the specification. These compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR).
    Type: Grant
    Filed: April 13, 2001
    Date of Patent: June 18, 2002
    Assignees: Novo Nordisk A/S, Dr. Reddy's Research foundation
    Inventors: Lone Jeppesen, Paul Stanley Bury, Per Sauerberg
  • Compounds, their preparation and use
    Publication number: 20020065267
    Abstract: The present invention relates to compounds of the general formula (I) 1
    Type: Application
    Filed: November 27, 2001
    Publication date: May 30, 2002
    Inventors: Lone Jeppesen, Paul Stanley Bury, Per Sauerberg
  • New compounds, their preparation and use
    Publication number: 20020065268
    Abstract: The present invention relates to compounds of the general formula (I) 1
    Type: Application
    Filed: November 27, 2001
    Publication date: May 30, 2002
    Inventors: Lone Jeppesen, Paul Stanley Bury, Per Sauerberg
  • Compounds, their preparation and use
    Publication number: 20020061876
    Abstract: The present invention relates to compounds of the general formula (I) 1
    Type: Application
    Filed: November 27, 2001
    Publication date: May 23, 2002
    Inventors: Lone Jeppesen, Paul Stanley Bury, Per Sauerberg
  • New compounds, their preparation and use
    Publication number: 20020061880
    Abstract: The present invention relates-to compounds of the general formula (I) 1
    Type: Application
    Filed: November 27, 2001
    Publication date: May 23, 2002
    Inventors: Lone Jeppesen, Paul Stanley Bury, Per Sauerberg
  • New compounds, their preparation and use
    Publication number: 20020055502
    Abstract: The present invention relates to compounds of the general formula (I) 1
    Type: Application
    Filed: November 27, 2001
    Publication date: May 9, 2002
    Inventors: Lone Jeppesen, Paul Stanley Bury, Per Sauerberg
  • Compounds, their preparation and use
    Patent number: 6369055
    Abstract: The present invention relates to compounds of the general formula (I) The compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR).
    Type: Grant
    Filed: April 18, 2000
    Date of Patent: April 9, 2002
    Assignee: Novo Nordisk A/S
    Inventors: Lone Jeppesen, Per Sauerberg, Anthony Murray, Paul Stanley Bury
  • Compounds, their preparation and use
    Patent number: 6365586
    Abstract: The present invention relates to compounds of the general formula (I) The compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR).
    Type: Grant
    Filed: October 19, 1999
    Date of Patent: April 2, 2002
    Assignees: Novo Nordisk A/S, Dr. Reddy's Research Foundation
    Inventors: Lone Jeppesen, Paul Stanley Bury, Per Sauerberg
  • Compounds, their preparation and use
    Patent number: 6353018
    Abstract: The present invention relates to compounds of the general formula (I) The compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR).
    Type: Grant
    Filed: October 19, 1999
    Date of Patent: March 5, 2002
    Assignees: Novo Nordisk A/S, Dr. Reddy's Research Foundation
    Inventors: Lone Jeppesen, Paul Stanley Bury, Per Sauerberg
  • New compounds, their preparation and use
    Publication number: 20020022656
    Abstract: The present invention relates to compounds of the general formula I.
    Type: Application
    Filed: April 13, 2001
    Publication date: February 21, 2002
    Inventors: Per Sauerberg, Lone Jeppesen, John Patrick Mogensen, Ingrid Pettersson, Paul Stanley Bury
  • New compounds, their preparation and use
    Publication number: 20020010171
    Abstract: The present invention relates to compounds of the general formula (I) 1
    Type: Application
    Filed: June 11, 2001
    Publication date: January 24, 2002
    Inventors: Lone Jeppesen, Per Sauerberg, Anthony Murray, Paul Stanley Bury
  • MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES)
    Publication number: 20020002199
    Abstract: The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) such as PTP1B, CD45, SHP-1, SHP-2, PTP&agr;, LAR and HePTP or the like.
    Type: Application
    Filed: March 11, 1999
    Publication date: January 3, 2002
    Inventors: LONE JEPPESEN, HENRIK SUNE ANDERSEN, OLE HVILSTED OLSEN, LUKE MILBURN JUDGE, DANIEL DALE HOLSWORTH, FARID BAKIR, FRANK URBAN AXE, YU GE
  • New compounds, their preparation and use
    Publication number: 20010041709
    Abstract: The present invention relates to compounds of formula (I) 1
    Type: Application
    Filed: January 26, 2001
    Publication date: November 15, 2001
    Inventors: John Patrick Mogensen, Per Sauerberg, Paul Stanley Bury, Lone Jeppesen, Ingrid Pettersson
  • Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
    Publication number: 20010031786
    Abstract: The present invention relates to compounds of formula (I) 1
    Type: Application
    Filed: April 13, 2001
    Publication date: October 18, 2001
    Inventors: Lone Jeppesen, Paul Stanley Bury, Per Sauerberg
  • Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors(PPAR)
    Publication number: 20010031764
    Abstract: The present invention relates to compounds of formula (I) 1
    Type: Application
    Filed: April 13, 2001
    Publication date: October 18, 2001
    Inventors: Lone Jeppesen, Paul Stanley Bury, Per Sauerberg
  • Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
    Publication number: 20010031762
    Abstract: The present invention relates to compounds of formula (I) 1
    Type: Application
    Filed: April 13, 2001
    Publication date: October 18, 2001
    Inventors: Lone Jeppesen, Paul Stanley Bury, Per Sauerberg
  • New compounds, their preparation and use
    Publication number: 20010029256
    Abstract: The present invention relates to compounds of formula (I) 1
    Type: Application
    Filed: March 14, 2001
    Publication date: October 11, 2001
    Inventors: Lone Jeppesen, Paul Stanley Bury, Per Sauerberg
  • Compounds, their preparation and use
    Patent number: 6300339
    Abstract: The present invention relates to compounds of formula (I) wherein A, B, Q, T, X, Y, Z, R5, R6, R7, R8, Ar, k, m, n and p are as defined in the specification. These compounds are useful in treating or preventing conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR).
    Type: Grant
    Filed: October 19, 1999
    Date of Patent: October 9, 2001
    Assignees: Novo Nordisk A/S, Dr. Reddy's Research Foundation
    Inventors: Lone Jeppesen, Paul Stanley Bury, Per Sauerberg
  • Compounds, their preparation and use
    Patent number: 6274608
    Abstract: Disclosed are novel compounds of formula I wherein R1, R2, R3, L, X and Y are as defined in the specification. These compounds are useful in the treatment of conditions mediated by nuclear receptors, in particular the Retinoid X Receptor (RXR) and the Peroxisome Proliferator-Activated Receptor (PPAR) families. Such conditions include diabetes and obesity.
    Type: Grant
    Filed: April 18, 2000
    Date of Patent: August 14, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Per Sauerberg, Anthony Murray, Lone Jeppesen, Paul Stanley Bury, Ingrid Pettersson